Literature DB >> 33584186

Pathophysiological Changes and the Role of Notch-1 Activation After Decompression in a Compressive Spinal Cord Injury Rat Model.

Xing Cheng1, Zhengran Yu1, Jinghui Xu1, Daping Quan2, Houqing Long1.   

Abstract

Surgical decompression is the primary treatment for cervical spondylotic myelopathy (CSM) patients with compressive spinal cord injury (CSCI). However, the prognosis of patients with CSCI varies, and the pathophysiological changes following decompression remain poor. This study aimed to investigate the pathophysiological changes and the role of Notch-1 activation after decompression in a rat CSCI model. Surgical decompression was conducted at 1 week post-injury (wpi). DAPT was intraperitoneally injected to down-regulate Notch-1 expression. Basso, Beattie, and Bresnahan scores and an inclined plane test were used to evaluate the motor function recovery. Hematoxylin and eosin staining was performed to assess pathophysiological changes, while hypoxia-inducible factor 1 alpha, vascular endothelial growth factor (VEGF), von Willebrand factor (vWF), matrix metalloproteinase (MMP)-9, MMP-2, Notch-1, and Hes-1 expression in the spinal cord were examined by immunohistochemical analysis or quantitative PCR. The results show that early decompression can partially promote motor function recovery. Improvements in structural and cellular damage and hypoxic levels were also observed in the decompressed spinal cord. Moreover, decompression resulted in increased VEGF and vWF expression, but decreased MMP-9 and MMP-2 expression at 3 wpi. Expression levels of Notch-1 and its downstream gene Hes-1 were increased after decompression, and the inhibition of Notch-1 significantly reduced the decompression-induced motor function recovery. This exploratory study revealed preliminary pathophysiological changes in the compressed and decompressed rat spinal cord. Furthermore, we confirmed that early surgical decompression partially promotes motor function recovery may via activation of the Notch-1 signaling pathway after CSCI. These results could provide new insights for the development of drug therapy to enhance recovery following surgery.
Copyright © 2021 Cheng, Yu, Xu, Quan and Long.

Entities:  

Keywords:  CSCI; Notch-1; decompression; motor function; pathophysiological changes

Year:  2021        PMID: 33584186      PMCID: PMC7876297          DOI: 10.3389/fnins.2021.579431

Source DB:  PubMed          Journal:  Front Neurosci        ISSN: 1662-453X            Impact factor:   4.677


  61 in total

1.  Analysis of dural configuration for evaluation of posterior decompression in cervical myelopathy.

Authors:  Y Ishida; K Ohmori; K Suzuki; H Inoue
Journal:  Neurosurgery       Date:  1999-01       Impact factor: 4.654

2.  Efficacy and safety of surgical decompression in patients with cervical spondylotic myelopathy: results of the AOSpine North America prospective multi-center study.

Authors:  Michael G Fehlings; Jefferson R Wilson; Branko Kopjar; Sangwook Tim Yoon; Paul M Arnold; Eric M Massicotte; Alexander R Vaccaro; Darrel S Brodke; Christopher I Shaffrey; Justin S Smith; Eric J Woodard; Robert J Banco; Jens R Chapman; Michael E Janssen; Christopher M Bono; Rick C Sasso; Mark B Dekutoski; Ziya L Gokaslan
Journal:  J Bone Joint Surg Am       Date:  2013-09-18       Impact factor: 5.284

3.  Experimental chronic compressive cervical myelopathy: effects of decompression.

Authors:  H L Harkey; O al-Mefty; I Marawi; D F Peeler; D E Haines; L F Alexander
Journal:  J Neurosurg       Date:  1995-08       Impact factor: 5.115

4.  Effects of surgery on cervical spondylotic myelopathy.

Authors:  J Wiberg
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

Review 5.  Role of hypoxia-induced VEGF in blood-spinal cord barrier disruption in chronic spinal cord injury.

Authors:  Hou-Qing Long; Guang-Sheng Li; Xing Cheng; Jing-Hui Xu; Fo-Bao Li
Journal:  Chin J Traumatol       Date:  2015

6.  Riluzole blocks perioperative ischemia-reperfusion injury and enhances postdecompression outcomes in cervical spondylotic myelopathy.

Authors:  Spyridon K Karadimas; Alex M Laliberte; Lindsay Tetreault; Young Sun Chung; Paul Arnold; Warren D Foltz; Michael G Fehlings
Journal:  Sci Transl Med       Date:  2015-12-02       Impact factor: 17.956

7.  Is the speed of chronic compression an important factor for chronic spinal cord injury rat model?

Authors:  Hou-Qing Long; Guang-Sheng Li; Er-Jian Lin; Wen-Han Xie; Wen-Li Chen; Keith Dip-Kei Luk; Yong Hu
Journal:  Neurosci Lett       Date:  2013-04-28       Impact factor: 3.046

8.  The prevalence and phenotype of activated microglia/macrophages within the spinal cord of the hyperostotic mouse (twy/twy) changes in response to chronic progressive spinal cord compression: implications for human cervical compressive myelopathy.

Authors:  Takayuki Hirai; Kenzo Uchida; Hideaki Nakajima; Alexander Rodriguez Guerrero; Naoto Takeura; Shuji Watanabe; Daisuke Sugita; Ai Yoshida; William E B Johnson; Hisatoshi Baba
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

9.  Value of micro-CT for monitoring spinal microvascular changes after chronic spinal cord compression.

Authors:  Hou-Qing Long; Wen-Han Xie; Wen-Li Chen; Wen-Lin Xie; Jing-Hui Xu; Yong Hu
Journal:  Int J Mol Sci       Date:  2014-07-07       Impact factor: 5.923

Review 10.  Current Diagnosis and Management of Cervical Spondylotic Myelopathy.

Authors:  Joshua Bakhsheshian; Vivek A Mehta; John C Liu
Journal:  Global Spine J       Date:  2017-05-31
View more
  1 in total

1.  Drug Discovery in Spinal Cord Injury With Ankylosing Spondylitis Identified by Text Mining and Biomedical Databases.

Authors:  Chenfeng Wang; Hongdao Ma; Weiqing Wu; Xuhua Lu
Journal:  Front Genet       Date:  2022-02-25       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.